A recent study indicated that TREM2 macrophages not only secreted IL-18 BP to inhibit the impact of IL-18 on NK cells but also alleviated the DC-derived IL-15, which drives NK cell dysfunction in lung cancer and provides a deeper insight into dual targeting of NK cells and TAMs [107]. The gene discussed is IL18; the disease is lung carcinoma.